Antibiotic prescriptions in Italian hospitalised children after serial point prevalence surveys (or pointless prevalence surveys): has anything actually changed over the years?


Journal

Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759

Informations de publication

Date de publication:
17 Oct 2019
Historique:
received: 30 06 2019
accepted: 21 09 2019
entrez: 19 10 2019
pubmed: 19 10 2019
medline: 3 4 2020
Statut: epublish

Résumé

Point prevalence surveys have been used in several studies to provide immediate and easily comparable information about antibiotic use and showed that about one third of hospitalised children had on ongoing antimicrobial prescription during their hospital admission. The aim of this study, as part of the Global Antimicrobial Resistance, Prescribing and Efficacy in Neonates and Children project, is to describe antimicrobial prescriptions among hospitalised children in four tertiary care hospitals in Italy to show if something has changed over the years. Four tertiary care Italian's hospitals joined three Point Prevalence Surveys (PPSs) in three different period of the year. All children under 18 years of age with an ongoing antimicrobial prescription, admitted on the participating wards at 8 o'clock in the morning of the selecting day were enrolled. A total of 1412 patients (475 neonates and 937 children) were admitted in the days of three PPSs. Overall, among the total admitted patients, 565 patients (40%) had an ongoing antimicrobial prescription in the days of the survey A total of 718 antibiotics were administered in the 485 admitted children and 133 in neonates. The most common indications for antibiotic therapy in children was Lower respiratory tract infections (244/718, 34%), while in neonates were prophylaxis for medical problems (35/133, 26.3%), newborn prophylaxis for newborn risk factors (29/133, 21.8%) and prophylaxis for surgical disease (15/133, 11.3%). Based on our results, it appears that nothing has changed since the last PPS and that the quality improved targets, underlyined in previous studies, are always the same. Serial PPSs can be part of AMS strategies but they are not sufficient alone to produce changes in clinical practice.

Sections du résumé

BACKGROUND BACKGROUND
Point prevalence surveys have been used in several studies to provide immediate and easily comparable information about antibiotic use and showed that about one third of hospitalised children had on ongoing antimicrobial prescription during their hospital admission. The aim of this study, as part of the Global Antimicrobial Resistance, Prescribing and Efficacy in Neonates and Children project, is to describe antimicrobial prescriptions among hospitalised children in four tertiary care hospitals in Italy to show if something has changed over the years.
METHODS METHODS
Four tertiary care Italian's hospitals joined three Point Prevalence Surveys (PPSs) in three different period of the year. All children under 18 years of age with an ongoing antimicrobial prescription, admitted on the participating wards at 8 o'clock in the morning of the selecting day were enrolled.
RESULTS RESULTS
A total of 1412 patients (475 neonates and 937 children) were admitted in the days of three PPSs. Overall, among the total admitted patients, 565 patients (40%) had an ongoing antimicrobial prescription in the days of the survey A total of 718 antibiotics were administered in the 485 admitted children and 133 in neonates. The most common indications for antibiotic therapy in children was Lower respiratory tract infections (244/718, 34%), while in neonates were prophylaxis for medical problems (35/133, 26.3%), newborn prophylaxis for newborn risk factors (29/133, 21.8%) and prophylaxis for surgical disease (15/133, 11.3%).
CONCLUSIONS CONCLUSIONS
Based on our results, it appears that nothing has changed since the last PPS and that the quality improved targets, underlyined in previous studies, are always the same. Serial PPSs can be part of AMS strategies but they are not sufficient alone to produce changes in clinical practice.

Identifiants

pubmed: 31623633
doi: 10.1186/s13052-019-0722-y
pii: 10.1186/s13052-019-0722-y
pmc: PMC6798353
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

127

Références

J Antimicrob Chemother. 2016 Apr;71(4):1106-17
pubmed: 26747104
Euro Surveill. 2008 Oct 09;13(41):
pubmed: 18926104
Lancet Glob Health. 2019 Jul;7(7):e861-e871
pubmed: 31200888
Semin Perinatol. 2012 Dec;36(6):431-6
pubmed: 23177802
Pediatr Infect Dis J. 2013 Jun;32(6):e242-53
pubmed: 23838740
Br J Clin Pharmacol. 2015 Mar;79(3):446-55
pubmed: 24433393
Infect Control Hosp Epidemiol. 2012 Apr;33(4):322-7
pubmed: 22418625
J Pediatric Infect Dis Soc. 2019 May 11;8(2):143-151
pubmed: 29579259
J Paediatr Child Health. 2013 Mar;49(3):185-92
pubmed: 21679337
PLoS One. 2016 May 16;11(5):e0154662
pubmed: 27182926

Auteurs

Chiara Tersigni (C)

Institute for Infection and Immunity, Paediatric Infectious Disease Research Group, St. George's, University of London, London, England. chia88.te@gmail.com.
Post graduate school of Paediatrics, University of Florence, Florence, Italy. chia88.te@gmail.com.
Department of Health Sciences, University of Florence, Anna Meyer Children's University Hospital, Viale Pieraccini 24, 50139, Florence, Italy. chia88.te@gmail.com.

Carlotta Montagnani (C)

Department of Health Sciences, University of Florence, Anna Meyer Children's University Hospital, Viale Pieraccini 24, 50139, Florence, Italy.

Patrizia D'Argenio (P)

Unit of Immune and Infectious Diseases, Academic Department of Pediatrics, Children's Hospital Bambino Gesù, Rome, Italy.

Marzia Duse (M)

Department of Pediatrics, La Sapienza University of Rome, Rome, Italy.

Susanna Esposito (S)

Pediatric Clinic, Department of Surgical and Biomedical Sciences, University of Perugia, Perugia, Italy.

Yingfen Hsia (Y)

Institute for Infection and Immunity, Paediatric Infectious Disease Research Group, St. George's, University of London, London, England.

Mike Sharland (M)

Institute for Infection and Immunity, Paediatric Infectious Disease Research Group, St. George's, University of London, London, England.

Luisa Galli (L)

Department of Health Sciences, University of Florence, Anna Meyer Children's University Hospital, Viale Pieraccini 24, 50139, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH